Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution.
COVID-19
degranulation activity
granzymes
innate immunity
natural killer
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Jun 2022
13 Jun 2022
Historique:
received:
27
05
2022
revised:
09
06
2022
accepted:
10
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
NK degranulation plays an important role in the cytotoxic activity of innate immunity in the clearance of intracellular infections and is an important factor in the outcome of the disease. This work has studied NK degranulation and innate immunological profiles and functionalities in COVID-19 patients and its association with the severity of the disease. A prospective observational study with 99 COVID-19 patients was conducted. Patients were grouped according to hospital requirements and severity. Innate immune cell subpopulations and functionalities were analyzed. The profile and functionality of innate immune cells differ between healthy controls and severe patients; CD56dim NK cells increased and MAIT cells and NK degranulation rates decreased in the COVID-19 subjects. Higher degranulation rates were observed in the non-severe patients and in the healthy controls compared to the severe patients. Benign forms of the disease had a higher granzymeA/granzymeB ratio than complex forms. In a multivariate analysis, the degranulation capacity resulted in a protective factor against severe forms of the disease (OR: 0.86), whereas the permanent expression of NKG2D in NKT cells was an independent risk factor (OR: 3.81; AUC: 0.84). In conclusion, a prompt and efficient degranulation functionality in the early stages of infection could be used as a tool to identify patients who will have a better evolution.
Identifiants
pubmed: 35743021
pii: ijms23126577
doi: 10.3390/ijms23126577
pmc: PMC9224310
pii:
doi:
Substances chimiques
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundación Mutua Madrileña
ID : P177122021
Organisme : Instituto de Salud Carlos III
ID : PI20-01361
Références
Cancers (Basel). 2021 Jan 26;13(3):
pubmed: 33530509
Physiology (Bethesda). 2020 Sep 1;35(5):288-301
pubmed: 32783610
PLoS Pathog. 2017 Feb 16;13(2):e1006155
pubmed: 28207896
Front Immunol. 2021 May 26;12:665329
pubmed: 34122423
Biomedicines. 2022 Jan 27;10(2):
pubmed: 35203509
ACR Open Rheumatol. 2021 Apr;3(4):267-276
pubmed: 33738987
Nat Immunol. 2008 May;9(5):495-502
pubmed: 18425106
Hum Genet. 2022 Jul;141(7):1279-1286
pubmed: 35182234
J Cell Mol Med. 2016 Jul;20(7):1339-51
pubmed: 27028780
Front Immunol. 2020 Aug 11;11:1991
pubmed: 32903476
Nat Rev Immunol. 2022 Feb;22(2):112-123
pubmed: 34117484
Cell Signal. 2020 Dec;76:109804
pubmed: 33035645
EMBO J. 2004 Jan 28;23(2):255-9
pubmed: 14685277
J Infect Dis. 2018 Oct 20;218(11):1822-1832
pubmed: 29554301
J Allergy Clin Immunol. 2014 Jul;134(1):218-21
pubmed: 24636087
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Int J Biol Sci. 2022 Jan 1;18(2):459-472
pubmed: 35002503
Front Immunol. 2021 May 03;12:659018
pubmed: 34012444
Mediators Inflamm. 2013;2013:343268
pubmed: 24307760
Immunity. 2021 Nov 9;54(11):2650-2669.e14
pubmed: 34592166
BMC Med. 2020 Jul 15;18(1):214
pubmed: 32664932
Front Immunol. 2015 May 13;6:226
pubmed: 26029211
Front Immunol. 2020 May 27;11:1014
pubmed: 32536923
Curr Opin Virol. 2016 Feb;16:15-23
pubmed: 26590692
J Leukoc Biol. 2021 Jan;109(1):55-66
pubmed: 32930456
Front Immunol. 2020 May 19;11:931
pubmed: 32508827
Pediatrics. 2020 Aug;146(2):
pubmed: 32680878
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
J Immunol. 2015 Jan 15;194(2):491-7
pubmed: 25556251
Front Cell Infect Microbiol. 2021 Feb 26;11:624483
pubmed: 33718270
Blood Adv. 2020 Oct 27;4(20):5035-5039
pubmed: 33075136
Trends Immunol. 2009 Mar;30(3):117-23
pubmed: 19217825
Scand J Immunol. 2002 Mar;55(3):221-8
pubmed: 11940227
Int J Med Sci. 2021 Jul 22;18(14):3236-3248
pubmed: 34400893
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Annu Rev Cell Dev Biol. 2007;23:495-517
pubmed: 17506701
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
Cell Microbiol. 2015 Nov;17(11):1537-60
pubmed: 26045209
J Immunol. 2011 Jul 1;187(1):401-11
pubmed: 21642541
Front Immunol. 2020 Jan 14;10:3083
pubmed: 31993061
Nat Rev Immunol. 2015 Jun;15(6):388-400
pubmed: 25998963
Blood. 2004 Nov 1;104(9):2840-8
pubmed: 15238416
Int J Mol Sci. 2020 Sep 01;21(17):
pubmed: 32883007
Int J Infect Dis. 2021 Apr;105:522-524
pubmed: 33711520
Am J Clin Pathol. 2013 Jun;139(6):713-27
pubmed: 23690113
Front Genet. 2020 Sep 18;11:937
pubmed: 33193576
Am J Pathol. 2010 Feb;176(2):1038-49
pubmed: 20035050
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
Front Immunol. 2012 Nov 09;3:335
pubmed: 23162553
Nat Immunol. 2018 Dec;19(12):1352-1365
pubmed: 30420626
Clin Vaccine Immunol. 2011 Sep;18(9):1410-5
pubmed: 21734066
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Biomedicines. 2021 Jan 09;9(1):
pubmed: 33435454
Viruses. 2017 Oct 12;9(10):
pubmed: 29023371
J Immunol. 2008 Jun 15;180(12):7785-91
pubmed: 18523242
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Int J Mol Sci. 2019 Oct 30;20(21):
pubmed: 31671661
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Infect Immun. 2017 Sep 20;85(10):
pubmed: 28760930
Front Cell Infect Microbiol. 2019 Jul 03;9:241
pubmed: 31334134
Eur J Immunol. 2005 Sep;35(9):2608-16
pubmed: 16106370
Nat Commun. 2016 Jun 23;7:11653
pubmed: 27337592
J Clin Invest. 2020 Sep 1;130(9):4694-4703
pubmed: 32463803
J Clin Med. 2021 May 20;10(10):
pubmed: 34065316
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265
Virulence. 2021 Dec;12(1):918-936
pubmed: 33757410
Am J Transplant. 2005 Mar;5(3):494-9
pubmed: 15707403
Blood. 2011 Apr 7;117(14):3799-808
pubmed: 21289310
Ups J Med Sci. 2015;120(4):257-62
pubmed: 26212358
Scand J Clin Lab Invest. 2021 Dec;81(8):679-686
pubmed: 34762008
J Innate Immun. 2017;9(2):111-125
pubmed: 28006777
Front Immunol. 2021 Mar 11;12:655934
pubmed: 33777054
J Biol Chem. 2019 Sep 13;294(37):13638-13656
pubmed: 31337704
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Cancer Immunol Res. 2015 Jun;3(6):575-82
pubmed: 26041808
Trends Immunol. 2018 Mar;39(3):222-239
pubmed: 29397297
Sci Immunol. 2020 Sep 28;5(51):
pubmed: 32989174